Chief Medical Officer and President of R&D Greater China
• MSD Global Vice President and General Manager of R&D Center China. Under Dr. Li’s leadership, MSD China has been responsible for the successful approvals of more than 20 product filings since 2011. Between 2017 and 2018, Dr. Li and his team delivered more than ten product approvals in China including Keytruda, Zepatier, Isentress, HPV vaccines (Gardasil and Gardasil 9).
• Ph.D. in Biostatistics from University of Wisconsin-Madison.